Reyon Pharmaceutical Co Ltd Net Asset Quality Index
Reyon Pharmaceutical Co Ltd net asset quality index. Reyon Pharmaceutical Co Ltd (102460) has a Net Asset Quality Index of 49.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩473.11 Billion minus total liabilities of ₩239.99 Billion yields net assets of ₩233.12 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 102460 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Reyon Pharmaceutical Co Ltd (2008–2024)
Net asset quality index of Reyon Pharmaceutical Co Ltd from 2008 to 2024. This chart shows how Reyon Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2008 to 2024. As of September 2025, the index stands at 49.3%, representing net assets of ₩233.12 Billion against total assets of ₩473.11 Billion KRW. See 102460 net assets for net asset value and shareholders' equity analysis.
Reyon Pharmaceutical Co Ltd Net Asset Quality Index by Year (2008–2024)
Reyon Pharmaceutical Co Ltd net asset quality index by year from 2008 to 2024. The table below presents the year-by-year Net Asset Quality Index for Reyon Pharmaceutical Co Ltd from 2008 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Reyon Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.0% | ₩249.94 Billion | ₩499.99 Billion | ₩250.05 Billion | ▲ +0.2 pp |
| 2023 | 49.7% | ₩248.62 Billion | ₩499.78 Billion | ₩251.15 Billion | ▼ -1.4 pp |
| 2022 | 51.1% | ₩247.77 Billion | ₩484.69 Billion | ₩236.93 Billion | ▼ -0.2 pp |
| 2021 | 51.3% | ₩245.24 Billion | ₩477.98 Billion | ₩232.74 Billion | ▼ -21.1 pp |
| 2020 | 72.4% | ₩230.09 Billion | ₩317.61 Billion | ₩87.52 Billion | ▼ -8.5 pp |
| 2019 | 81.0% | ₩222.29 Billion | ₩274.48 Billion | ₩52.19 Billion | ▲ +6.6 pp |
| 2018 | 74.3% | ₩225.39 Billion | ₩303.17 Billion | ₩77.77 Billion | ▼ -1.2 pp |
| 2017 | 75.5% | ₩219.66 Billion | ₩290.84 Billion | ₩71.18 Billion | ▼ -9.9 pp |
| 2016 | 85.5% | ₩179.10 Billion | ₩209.54 Billion | ₩30.44 Billion | ▲ +5.0 pp |
| 2012 | 80.5% | ₩126.36 Billion | ₩156.92 Billion | ₩30.57 Billion | ▲ +1.9 pp |
| 2011 | 78.6% | ₩105.47 Billion | ₩134.20 Billion | ₩28.73 Billion | ▲ +5.6 pp |
| 2009 | 73.0% | ₩59.76 Billion | ₩81.91 Billion | ₩22.15 Billion | ▲ +7.6 pp |
| 2008 | 65.3% | ₩42.63 Billion | ₩65.27 Billion | ₩22.64 Billion | — |